XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Deficit
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2020     355,400,000        
Beginning Balance at Dec. 31, 2020 $ 605 $ 535 $ 10,227 $ 454 $ (8,013) $ (2,133) $ 70
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     3,300,000        
Common shares issued under share-based compensation plans 15 15 $ 73 (58)      
Share-based compensation 62 62   62      
Employee withholding taxes related to share-based awards (45) (45)   (45)      
Net (loss) income (1,200) (1,205)     (1,205)   5
Other comprehensive (loss) income (48) (49)       (49) 1
Ending Balance (in shares) at Jun. 30, 2021     358,700,000        
Ending Balance at Jun. 30, 2021 (611) (687) $ 10,300 413 (9,218) (2,182) 76
Beginning Balance (in shares) at Mar. 31, 2021     358,100,000        
Beginning Balance at Mar. 31, 2021 (124) (197) $ 10,289 393 (8,623) (2,256) 73
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     600,000        
Common shares issued under share-based compensation plans 4 4 $ 11 (7)      
Share-based compensation 31 31   31      
Employee withholding taxes related to share-based awards (4) (4)   (4)      
Net (loss) income (593) (595)     (595)   2
Other comprehensive (loss) income 75 74       74 1
Ending Balance (in shares) at Jun. 30, 2021     358,700,000        
Ending Balance at Jun. 30, 2021 $ (611) (687) $ 10,300 413 (9,218) (2,182) 76
Beginning Balance (in shares) at Dec. 31, 2021 359,405,748   359,400,000        
Beginning Balance at Dec. 31, 2021 $ (34) (106) $ 10,317 462 (8,961) (1,924) 72
Increase (Decrease) in Shareholders' Equity              
Proceeds from B+L initial public offering, net of costs (Note 2) 675 (190)   (327)   137 865
Common shares issued under share-based compensation plans (in shares)     2,200,000        
Common shares issued under share-based compensation plans 3 3 $ 63 (60)      
Share-based compensation 58 58   58      
Employee withholding taxes related to share-based awards (29) (29)   (29)      
Net (loss) income (205) (214)     (214)   9
Other comprehensive (loss) income $ (215) (215)       (215)  
Ending Balance (in shares) at Jun. 30, 2022 361,571,921   361,600,000        
Ending Balance at Jun. 30, 2022 $ 253 (693) $ 10,380 104 (9,175) (2,002) 946
Beginning Balance (in shares) at Mar. 31, 2022     361,300,000        
Beginning Balance at Mar. 31, 2022 (141) (216) $ 10,373 415 (9,030) (1,974) 75
Increase (Decrease) in Shareholders' Equity              
Proceeds from B+L initial public offering, net of costs (Note 2) 675 (190)   (327)   137 865
Common shares issued under share-based compensation plans (in shares)     300,000        
Common shares issued under share-based compensation plans 1 1 $ 7 (6)      
Share-based compensation 26 26   26      
Employee withholding taxes related to share-based awards (4) (4)   (4)      
Net (loss) income (139) (145)     (145)   6
Other comprehensive (loss) income $ (165) (165)       (165)  
Ending Balance (in shares) at Jun. 30, 2022 361,571,921   361,600,000        
Ending Balance at Jun. 30, 2022 $ 253 $ (693) $ 10,380 $ 104 $ (9,175) $ (2,002) $ 946